This sculpture by the sculptor Günter Steinmann will be presented to all award winners. It translates creative activity into artistic design language and thus creates a lasting symbol.
Professor Dr. Erhard Meyer-Galow has mainly worked at the interface between chemistry and the market in his professional life. That is why business chemistry runs like a red thread through his professional work. During his time as President of the GDCh in 1998/1999, Professor Meyer-Galow campaigned particularly for the establishment of the "Vereinigung Chemie und Wirtschaft (VCW)" in the GDCh and for the establishment of a "Business Chemistry" course at German universities. In order to accelerate this course of study, HÜLS AG established the endowed professorship "Business Administration for Natural Sciences, especially Chemistry" at the Westphalian Wilhelms University in Münster for a period of five years for a period of five years under his leadership. This chair was the first of its kind in Germany and continues to train business chemists very successfully to this day. The founder himself gave lectures on "Business Chemistry in the Chemical Industry" at the Westphalian Wilhelms University in Münster for many years. Prof. Dr. Erhard Meyer-Galow was appointed honorary professor on July 28, 1998 and received the Federal Cross of Merit on ribbon on October 20, 1998 for his diverse achievements.
To further promote business chemistry, especially from the point of view of sustainability and the need for chemical products or processes with high value for our society, he founded the "Meyer-Galow Foundation for Business Chemistry", whose task is the annual award of the "Meyer-Galow Prize for Business Chemistry" is. The foundation is administered by the GDCh in accordance with the decision of the board of the German Chemical Society eV on March 5, 2012. Endowments are welcome.
The prize is endowed with 10,000 euros.
It is awarded to people who - alone or with a team - have successfully introduced a current innovation in chemistry to the market in German-speaking countries. It can be a product or a process. The invention that is brought to innovation can, but does not have to, come from himself. However, he should be the driving force for implementation in the market.
The award awardee proves to be worthy in particular if he or she
Dr. Werner Bonrath, DSM, Kaiseraugst/Switzerland, was honored in recognition of his contributions to the development of a more sustainable synthesis of vitamin E. It is thanks to his excellent research and the subsequent successful industrial implementation and market launch that the two key building blocks 2,3,5-trimethylhydroquinone and isophytol can be produced more cost-effectively and with lower energy consumption. This made it possible to significantly reduce the CO 2 balance, which is an important step towards sustainable production.
Dr. Oliver Schadt, Merck, Darmstadt, received the award in recognition of his contributions to the identification and development of the small molecule drug tepotinib. Tepotinib is a targeted cancer therapy approved in Europe and worldwide for patients with metastatic non-small cell lung cancer (NSCLC) with MET exon 14 skipping alterations and represents an innovative and effective therapeutic option for an unmet medical need. The successful market launch is thanks in particular to his innovative thinking and his inclusive and team-oriented leadership style.
Drs. Götz Baumgarten, Axel Kobus and Jörg Balster, Evonik Operations GmbH, convinced the foundation advisory board with their development of the hollow-fiber membranes made from polyimides known under the brand name SEPURAN. Within a very short time, they and their team have succeeded in developing and bringing to market a gas separation membrane that is the leading biogas upgrading technology today.
Dr. Edgar Endlein, Werner and Mertz GmbH, was honored for his many years of commitment to innovation and sustainability management. He successfully promoted the well-known consumer goods brand Frosch with innovative and sustainable products based on regional European vegetable oils in the cosmetics and detergents industry.
Dr. Roland Bayer, Application Development Leader, DuPont N&B, received the award for the development and commercialization of a thermoplastic hydroxy-propylmethylcellulose (HPMC). Filaments produced from this are used as a support material in 3D printing and can be washed out with simple tap water after the printing process. They are fully recyclable.
Dr. Markus Rarbach, Clariant, for the development and successful market launch of the highly complex sunliquid® technology. Fossil fuel sources are being replaced by cellulosic ethanol. A practically greenhouse gas-neutral biofuel is thus made available.
Dr. Markus Heitzmann, Boehringer Ingelheim Pharma, was instrumental in the successful launch of Jardiance® (empagliflozin), an oral antidiabetic that also reduces the risk of cardiovascular events in patients with existing cardiovascular disease.
Dr. Thorsten Bartels, Boris Eisenberg, Dr. Klaus Schimossek, Dr. Torsten Stöhr, Evonik, was honored for the development of high-performance lubricants in vehicles, machines and systems for resource efficiency and reduced carbon dioxide emissions.
Dr. Andreas Lutz and Dr. Stefan Schmatloch, DOW, were honored for lightweight construction concepts in the automotive industry, especially for research and development of new adhesive technologies.
Dr. Michael Heckmeier, Dr. Harold Hirschmann, Dr. Sang-Kyu Lee, Dr. Roman Maisch, Merck KGaA. The team works in liquid crystal research and was recognized for developing liquid crystal formulations for energy-efficient smartphones and tablets.
Dr. Thomas Greindl, BASF, succeeded in developing and successfully launching easily biodegradable surfactants and complexing agents, especially TRILON ® M, a powerful alternative to phosphates.
Dr. Susanne Röhrig, Bayer AG, was the first to receive this award for her contribution to the discovery and development of the novel anticoagulant rivaroxaban. Launch of the innovative thrombosis drug Xarelto.
The work to fulfill the foundation's purpose is carried out by an advisory board. If possible, the following should be represented on this board of trustees alongside the founder:
Prof. Dr. Erhard MEYER-GALOW, Essen (founder and Chair of the foundation)
Dr. Felix MÜLLER, Evonik Industries AG, Essen (Secretary of the Foundation)
Dr. Matthias URMANN, Frankfurt aM
Prof. Michael DRÖSCHER, Dorsten
Dr. Martin VOLLMER, BMI Group/United Kingdom
Dr. Carla SEIDEL, BASF/Ludwigshafen
Prof. Jens LEKER, Münster
The nomination must be accompanied by the following documents:
The 2023 awardee is Dr. Dennis Lippmann, thysenkrupp Uhde GmbH.
Dr. Felix Müller has been the Foundation Secretary of the Meyer Galow Foundation for Business Chemistry since 2020. Contact: felix.mueller@evonik.com
The founder has set up his own website, which also explains the reasons for setting up his foundation.
© Photo
Agency
FOX
Dr. Jasmin Herr
Varrentrappstr. 40 - 42
60486 Frankfurt aM
Tel. +49 69 7917-323
Fax +49 69 7917-1323
Email: j.herr@gdch.de
This page has been machine translated. If you have any feedback or comments please feel free to contact us. 
last modified: 21.11.2023 09:59 H from Translator
